510(k) K262639
K262639 is an FDA 510(k) premarket notification submitted by Spineart SA for the device "BAGUERA® C Cervical Disc Surgical Instruments". The FDA issued a decision of Substantially Equivalent on August 14, 2026. The device falls under product code QLQ (Manual Instruments Designed For Use With Total Disc Replacement Devices), a Class II device regulated under 21 CFR 888.4515. Spineart SA has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 14, 2026
- Date Received
- July 29, 2026
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Manual Instruments Designed For Use With Total Disc Replacement Devices
- Device Class
- Class II
- Regulation Number
- 888.4515
- Review Panel
- OR
- Submission Type
The devices are intended to manipulate tissue or implant materials for the positioning, alignment, defect creation, placement, or removal of total disc replacement devices.